Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran

Background and Aims: Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran. Methods: This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients’ demographic characteristics, questions about patients’ knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients’ characteristics (exposure) with vaccination coverage (outcome) was investigated. Results: The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (p < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [p = 0.001, odds ratio (OR) = 1.04] and patients’ knowledge (p < 0.001, OR = 1.42) with the vaccination coverage. Conclusion: The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.

[1]  T. Uyeki High-risk Groups for Influenza Complications. , 2020, JAMA.

[2]  A. Odone,et al.  Influenza vaccination coverage in patients with diabetes mellitus afferent to an Italian hospital , 2020 .

[3]  M. Grijalva,et al.  Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador , 2020, BMC Public Health.

[4]  A. Agodi,et al.  Factors predicting influenza vaccination adherence among patients in dialysis: an Italian survey , 2019, Human vaccines & immunotherapeutics.

[5]  B. Cowling,et al.  Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. , 2018, Vaccine.

[6]  L. Bakhireva,et al.  Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists , 2018, Research in social & administrative pharmacy : RSAP.

[7]  H. Hwang,et al.  Factors influencing on influenza vaccination and its trends of coverage in patients with diabetes in Korea: A population-based cross-sectional study. , 2018, Vaccine.

[8]  C. Wiysonge,et al.  A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. , 2017, Vaccine.

[9]  P. V. van Genderen,et al.  Benefits of flu vaccination for persons with diabetes mellitus: A review. , 2017, Vaccine.

[10]  D. Stefanidis,et al.  Seasonal influenza vaccination in patients with COPD: a systematic literature review , 2017, BMC Pulmonary Medicine.

[11]  Lin Yang,et al.  Influenza vaccination in older people with diabetes and their household contacts. , 2017, Vaccine.

[12]  R. Jiménez-García,et al.  Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study. , 2017, Vaccine.

[13]  A. Srivastav,et al.  Uptake of Influenza Vaccination and Missed Opportunities Among Adults with High-Risk Conditions, United States, 2013. , 2016, The American journal of medicine.

[14]  P. Bakke,et al.  Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. , 2016, Respiratory medicine.

[15]  T. Kitazono,et al.  Influenza Vaccination and Other Factors Related to the Development of Influenza‐Like Illness Among Patients on Chronic Hemodialysis in a Japanese Dialysis Facility , 2016, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[16]  F. Vitale,et al.  Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy , 2016, Journal of preventive medicine and hygiene.

[17]  F. Najafi,et al.  Influenza vaccination uptake and its socioeconomic determinants in the older adult Iranian population: A national study. , 2015, American journal of infection control.

[18]  J. Noh,et al.  Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea , 2015, Infection & chemotherapy.

[19]  S. Olsen,et al.  Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010–2012 , 2014, Vaccine.

[20]  B. Honarvar,et al.  Immunization status of general hospitals' staff against Influenza, Shiraz , Southern of Iran , 2012 .

[21]  M. McLaws,et al.  Influenza vaccination uptake among students and clinical staff of a university in Iran. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[22]  M. Unruh,et al.  Influenza vaccine delivery and effectiveness in end-stage renal disease. , 2003, Kidney international.

[23]  C. Bridges,et al.  Influenza Vaccination Coverage Among People With High-Risk Conditions in the U.S. , 2016, American journal of preventive medicine.

[24]  松本 慶蔵,et al.  季節性インフルエンザ(Seasonal Influenza)の総括 , 2009 .